pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol PPP1R2   
Synonyms IPP-2, IPP2
Description protein phosphatase 1 regulatory inhibitor subunit 2
Transcript NM_006241   
Expression
Putative miRNA Targets on PPP1R2
3'UTR of PPP1R2
(miRNA target sites are highlighted)
>PPP1R2|NM_006241|3'UTR
   1 ACGAGATTTGTTCAACACTGCAATTGTTTGTTAGATGTAAACCCTGTGACTATAGTACGTTGCTTCTTGTTCTTCACAAT
  81 TCATGACTTAAGTACCAAAATGCATACCAGTTATTATATATTGCCAAGAATTAAATGATAAACTTAGAGACTGATTAGAC
 161 TGAAAATGCCTAATCGATATATATATTCTTGTGCCTAGTACTTTACCACAAATACAGTGTAATATCATCAGTCCAAAACT
 241 GCATTACTTTTGTAAAAACACTGGTTAATTTGTATAAGATATTATAGAGCTTTTTATGCTTTAGAAGTTAAACAATATCT
 321 TTGGGGGGGAACTAATTTATTTTCATCACTTGAAATGTGGTAGCTCTTACAAAGTTTATTGATTTGATTTTTTTAAAAAT
 401 CAAAAGCCAATTGAACAACAGGATATATAGACTGATAAATATTTAGGCTGAATAGTATTTTAACACTTGTCTTCAACTTG
 481 ATTTGTCTGTTTAATTGAAAAGAATTATAAGAGTTACTGTTGCATTTTCTGACCTACTATTTTTAAAATTCCTGTTGAGT
 561 TTCTTTGTGTTTACAAGGAAAGGACTGAACTTTTTCTCATCAAAACTAGCTTTTTTCCCCACAAATAAATTATCAGGTTA
 641 AACTTTCACCAATGTCTGCTCTGTTTTTTGTTTTTGGGGGGTTTTTGTTTGTTTTTGTTTTTTAATGTTTTTGGTACACT
 721 GGGCAGACTTCAGAGCAGTTTTTTAAAAAAATAAATATTCTAATGTAGCTATCTCGCCATTCCCTTTAAATACCTGTCTT
 801 AACCTCCTGCTTTTCTTTCCTACTCCTTTCCACACATACGCACACAATCTTCTACCTTTTAAAGGATCATTAAGACTGTC
 881 ACCACATTAGGAGCTCTTTCTCTCACTCTTCTGTCATTTGCTGCTATGTTGAAATTCTTATTTTGACCATCAATGCCTAT
 961 GAATTCTTCTAATACGTGAAGAAAATAGTTTGAGTAGCAGCAGTGCTATAGGTGGGAAATACAGTTTAGCTGCTGAATTT
1041 CTATACCTCTCTGATTTACAGATTGCTAATTAAATGGCTATTATTAGTTTGGATTAATTAGACTTAAGAAAACAACTAAC
1121 TGAGGGTTTTTTTTGTTTGTTTTTTGAGGGTTTTCTTTGCATGAGAATTGTATGTAACCAGTGATATGATTATTCCTGAA
1201 TGTACAGACAGAAGTAAGCCTGGACATTGTTAAATAGTCCCTGCTTTAAGGGACTACGATAATGTGTACTATGACAAACG
1281 TGCTTTATTCTTCTAACGCAGTAAGAATTAGGTGGAATTTTTTCCTTCAACCAAGTGCAGGAAAGCCCTGTGTGTCTTGG
1361 TTTAGTTATGGTTTCATTTCTAGCCATACAATTGATGAATTGTGTACAACTTTTGTTAGTACCAAAATAATCTGTTATAT
1441 GAACAGACTTCTAAAATAACGTCTGTATATTTTATATATAGATACATATATGAAAGAAGGCTTTTATTGAACAGCTTATC
1521 TTCCACTTGCAGGTTTATGGAAACAGCAGTATTTGAAAATAAATAAAAAGTGGGAGAATTCCTTGCTGTTAGAAGAATGT
1601 GGCCATTATTTTGATTTTTTGAATGAGATATATAATCAAAGTACTGCTGAACTGTGAGTGCAGTATTCTAAACATTTCAG
1681 CTAGGAATACCACTGATTTAGAAACAAAACTGTTTGTCTCTGGTTTCTGAATTTAAAATGTTGGGATTACCTGTTTAAAT
1761 CTGTCTTGGGGGATGTAGAGATTAAGTCTGTACATGTGCGTGCACATATATTCATGCACCCTCTGATTTTGGTTTTCTTG
1841 TTTCTGAGTTCTTAGAAAGTACCCACATACTCTTTTTTTTTTTTTGTAGAAGTAGCTGTCATAGAGTGAAGAAAAGGATA
1921 AGACTTTAAACAGTTGATTCTTTTTGTGTTTTCTACAAACTATTTTTTGAAATTTAAATCACAAACTCATTTTCTGGTTT
2001 TTAGAAAGTAGATGATGATTTCAGAGGAGTAAGGCATGCCAAGCAGCATGCTCAGTGGGGTTTTAGGCTGTCACATGCAG
2081 CTGAGAAAAGGTATGTTCAAGTCATAAGTAGGTAATTGATAGGGTATGAACTAGTCAAAATATGAACCATTATGATTCAA
2161 GTTAGATTTTCCTCTGGAGAGACAGATCTGAATGTTCAGTTCTAGCCAAGGTAGATTTTACTTTCAACTTTTTAATCAGT
2241 ATCACTTTCTGTGCTTAACTATTTGGTGTTACCTTGTCTGTTTTCATTTGTCTAAAATTCTGCAGAGATGACTAAAATTT
2321 GACATAATGGTGTAAATGGATTGTTAAGGTAACTTTCAGTTGAAGATTAAAGCAAGATGCCATTTTCCCCATGACTTTGG
2401 TTTTGTTTACATTTTTCCCTTTCAGTTAGTATACACTACACGTACTGTAATAAAATACAATAATATGACAATTG
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucggcgacaGUGUGCGUGUc 5'
                     ||:||||||| 
Target 5' tcctttccacaCATACGCACAc 3'
824 - 845 151.00 -15.20
2
miRNA  3' agucggCGACAGUGUGCGUguc 5'
                |||||||||:|||   
Target 5' ttttagGCTGTCACATGCAgct 3'
2061 - 2082 124.00 -21.22
3
miRNA  3' agUC-GGCG---ACAGUGUGCGUGUc 5'
            || |:|:   ||| :|::||||| 
Target 5' taAGTCTGTACATGT-GCGTGCACAt 3'
1783 - 1807 123.00 -13.90
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31590350 2 COSMIC
COSN31541097 21 COSMIC
COSN30490595 44 COSMIC
COSN30479058 48 COSMIC
COSN30657939 71 COSMIC
COSN30138004 105 COSMIC
COSN31539285 112 COSMIC
COSN31560380 128 COSMIC
COSN31605830 175 COSMIC
COSN30166214 178 COSMIC
COSN31538057 290 COSMIC
COSN26669873 312 COSMIC
COSN28650618 321 COSMIC
COSN31519826 381 COSMIC
COSN24501931 394 COSMIC
COSN20622155 426 COSMIC
COSN31546183 449 COSMIC
COSN6573625 498 COSMIC
COSN20185184 507 COSMIC
COSN31523456 627 COSMIC
COSN20099574 682 COSMIC
COSN20099573 1126 COSMIC
COSN31515253 1375 COSMIC
COSN24719000 1392 COSMIC
COSN9543087 1432 COSMIC
COSN8488943 1436 COSMIC
COSN8488942 1448 COSMIC
COSN22166191 1635 COSMIC
COSN9543086 1656 COSMIC
COSN31576160 1700 COSMIC
COSN26098704 1706 COSMIC
COSN1939940 1758 COSMIC
COSN31596549 1783 COSMIC
COSN5042519 1787 COSMIC
COSN5001691 1816 COSMIC
COSN31528940 1835 COSMIC
COSN18767168 1873 COSMIC
COSN20099571 1873 COSMIC
COSN29544614 2066 COSMIC
COSN9543085 2347 COSMIC
COSN9543084 2458 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs200803998 2 dbSNP
rs763764324 3 dbSNP
rs372687925 4 dbSNP
rs1442386993 8 dbSNP
rs760252470 9 dbSNP
rs751987628 14 dbSNP
rs775778173 15 dbSNP
rs772488220 21 dbSNP
rs545945970 22 dbSNP
rs1361644205 23 dbSNP
rs112276856 25 dbSNP
rs774880477 28 dbSNP
rs770895607 29 dbSNP
rs749346663 30 dbSNP
rs1381900861 37 dbSNP
rs1020763156 39 dbSNP
rs777718080 42 dbSNP
rs1448649425 51 dbSNP
rs988004624 52 dbSNP
rs527367382 58 dbSNP
rs1233280233 59 dbSNP
rs1300189280 59 dbSNP
rs1276139403 60 dbSNP
rs1322169178 66 dbSNP
rs1314427043 68 dbSNP
rs1223159339 98 dbSNP
rs1389255675 104 dbSNP
rs956316703 108 dbSNP
rs1266977104 116 dbSNP
rs1451280698 118 dbSNP
rs1033122070 121 dbSNP
rs866888800 128 dbSNP
rs1379456586 135 dbSNP
rs1000590414 152 dbSNP
rs560234245 156 dbSNP
rs889565396 157 dbSNP
rs1301707429 158 dbSNP
rs541460502 163 dbSNP
rs1386998373 172 dbSNP
rs1324885695 175 dbSNP
rs185451642 176 dbSNP
rs1014426272 183 dbSNP
rs896107038 184 dbSNP
rs1418669768 197 dbSNP
rs1355794689 201 dbSNP
rs9414 203 dbSNP
rs1388430081 206 dbSNP
rs1413020757 208 dbSNP
rs562652494 211 dbSNP
rs544464572 212 dbSNP
rs534071173 216 dbSNP
rs1355832517 220 dbSNP
rs1210718377 227 dbSNP
rs1269557744 229 dbSNP
rs1436195262 231 dbSNP
rs1489895105 247 dbSNP
rs1178548523 252 dbSNP
rs1266670670 261 dbSNP
rs576989511 274 dbSNP
rs1161986180 277 dbSNP
rs1368267923 279 dbSNP
rs1458084318 281 dbSNP
rs1164676097 282 dbSNP
rs1393663839 289 dbSNP
rs898899040 302 dbSNP
rs1037429255 312 dbSNP
rs943129462 313 dbSNP
rs910179167 314 dbSNP
rs987140986 315 dbSNP
rs1450371413 316 dbSNP
rs1314088244 317 dbSNP
rs1209237948 320 dbSNP
rs17847361 321 dbSNP
rs933214874 323 dbSNP
rs1236653846 324 dbSNP
rs539583423 326 dbSNP
rs1198049442 328 dbSNP
rs1288642348 329 dbSNP
rs1459438436 330 dbSNP
rs1182353247 331 dbSNP
rs1255900121 335 dbSNP
rs988360986 337 dbSNP
rs545517255 344 dbSNP
rs1370942206 347 dbSNP
rs1343171249 359 dbSNP
rs1401915295 360 dbSNP
rs1302237613 362 dbSNP
rs754971576 362 dbSNP
rs1387791755 369 dbSNP
rs1379602292 370 dbSNP
rs1051843 378 dbSNP
rs1318751222 388 dbSNP
rs1393538679 394 dbSNP
rs866382325 395 dbSNP
rs572204076 410 dbSNP
rs978829994 413 dbSNP
rs1453551136 417 dbSNP
rs970556573 418 dbSNP
rs1202307133 429 dbSNP
rs1255870067 432 dbSNP
rs1022913857 445 dbSNP
rs112931016 447 dbSNP
rs1014249562 451 dbSNP
rs751607439 454 dbSNP
rs573510834 457 dbSNP
rs1194012894 458 dbSNP
rs1433654296 465 dbSNP
rs1425106407 476 dbSNP
rs1479200668 477 dbSNP
rs181271931 480 dbSNP
rs1203136602 504 dbSNP
rs1359634699 509 dbSNP
rs1467528711 529 dbSNP
rs1286843852 531 dbSNP
rs558349705 532 dbSNP
rs1359730857 539 dbSNP
rs1051826 540 dbSNP
rs1051824 541 dbSNP
rs1464319366 545 dbSNP
rs34394132 545 dbSNP
rs1399625581 554 dbSNP
rs994170267 558 dbSNP
rs1268363296 567 dbSNP
rs1221721200 572 dbSNP
rs1300680996 577 dbSNP
rs1313239218 580 dbSNP
rs899310391 583 dbSNP
rs1488189044 594 dbSNP
rs1216863043 601 dbSNP
rs535491647 604 dbSNP
rs1320985432 607 dbSNP
rs1348744468 611 dbSNP
rs576619261 617 dbSNP
rs1434825015 619 dbSNP
rs1233373434 628 dbSNP
rs1379421405 632 dbSNP
rs1420032720 634 dbSNP
rs1333308028 636 dbSNP
rs1294124507 640 dbSNP
rs1299840048 643 dbSNP
rs1362617704 648 dbSNP
rs758577798 652 dbSNP
rs1368479062 660 dbSNP
rs752871718 664 dbSNP
rs765617679 670 dbSNP
rs1322975406 671 dbSNP
rs769999552 675 dbSNP
rs73208954 676 dbSNP
rs1241283081 682 dbSNP
rs74289311 682 dbSNP
rs1405656276 683 dbSNP
rs1442773996 687 dbSNP
rs397992020 687 dbSNP
rs1246780060 691 dbSNP
rs1175391861 698 dbSNP
rs1489199194 698 dbSNP
rs1237450242 701 dbSNP
rs1440242267 707 dbSNP
rs1467690224 727 dbSNP
rs760022916 728 dbSNP
rs1383212719 731 dbSNP
rs1403806566 731 dbSNP
rs1051423422 736 dbSNP
rs568408252 744 dbSNP
rs550230875 745 dbSNP
rs1448793197 751 dbSNP
rs1248346770 757 dbSNP
rs1190295387 758 dbSNP
rs1329434824 758 dbSNP
rs538510536 764 dbSNP
rs141840883 765 dbSNP
rs1311901877 775 dbSNP
rs1377525029 776 dbSNP
rs1227353831 782 dbSNP
rs1290209401 783 dbSNP
rs1323177287 793 dbSNP
rs552797073 794 dbSNP
rs1201740492 797 dbSNP
rs1256883930 799 dbSNP
rs1200514322 804 dbSNP
rs1052332828 808 dbSNP
rs527432222 811 dbSNP
rs371851653 816 dbSNP
rs1240999706 823 dbSNP
rs1228228311 828 dbSNP
rs925107335 828 dbSNP
rs1472370650 830 dbSNP
rs766947037 835 dbSNP
rs111444222 839 dbSNP
rs916022104 840 dbSNP
rs560296590 842 dbSNP
rs548231031 845 dbSNP
rs529677049 852 dbSNP
rs1357765254 854 dbSNP
rs148383414 865 dbSNP
rs1285159307 866 dbSNP
rs761298993 869 dbSNP
rs1380812537 877 dbSNP
rs1216475853 880 dbSNP
rs993723320 889 dbSNP
rs1394340522 890 dbSNP
rs963972071 892 dbSNP
rs1441797869 893 dbSNP
rs79884421 894 dbSNP
rs1239006441 905 dbSNP
rs1390739836 912 dbSNP
rs1170210757 917 dbSNP
rs1008178447 921 dbSNP
rs576715998 928 dbSNP
rs1442603701 935 dbSNP
rs1236526318 941 dbSNP
rs1478218822 941 dbSNP
rs1172937580 953 dbSNP
rs1423599561 960 dbSNP
rs1414412189 969 dbSNP
rs1335259417 974 dbSNP
rs116559925 975 dbSNP
rs77322963 990 dbSNP
rs867090409 992 dbSNP
rs1051540148 999 dbSNP
rs749873644 1011 dbSNP
rs143404058 1012 dbSNP
rs569491405 1022 dbSNP
rs936595242 1023 dbSNP
rs1280472600 1046 dbSNP
rs1487209526 1051 dbSNP
rs1244219510 1058 dbSNP
rs149181594 1068 dbSNP
rs1285159355 1087 dbSNP
rs367622625 1093 dbSNP
rs1376050407 1096 dbSNP
rs1136 1100 dbSNP
rs761361727 1101 dbSNP
rs1427668098 1103 dbSNP
rs1418198673 1121 dbSNP
rs1307450573 1122 dbSNP
rs775833711 1126 dbSNP
rs200656231 1127 dbSNP
rs574769189 1127 dbSNP
rs769545800 1131 dbSNP
rs1371067774 1132 dbSNP
rs201153201 1135 dbSNP
rs992851144 1135 dbSNP
rs1351450824 1139 dbSNP
rs1309845510 1143 dbSNP
rs2246343 1167 dbSNP
rs1412722258 1169 dbSNP
rs568108467 1170 dbSNP
rs1163639477 1178 dbSNP
rs1473548237 1181 dbSNP
rs1409352012 1188 dbSNP
rs1207187072 1205 dbSNP
rs1265318806 1206 dbSNP
rs1451154751 1211 dbSNP
rs1199697092 1227 dbSNP
rs1255397435 1236 dbSNP
rs919229806 1240 dbSNP
rs972506123 1257 dbSNP
rs1381383653 1261 dbSNP
rs79024179 1265 dbSNP
rs1161140787 1277 dbSNP
rs1016949947 1279 dbSNP
rs1220814717 1280 dbSNP
rs1324992573 1294 dbSNP
rs1374485731 1295 dbSNP
rs145356462 1297 dbSNP
rs953496591 1298 dbSNP
rs1030522467 1299 dbSNP
rs1241425727 1308 dbSNP
rs1263850662 1308 dbSNP
rs1355946008 1309 dbSNP
rs1210436290 1317 dbSNP
rs1348762642 1318 dbSNP
rs375194039 1319 dbSNP
rs997227782 1324 dbSNP
rs1229073863 1328 dbSNP
rs780986130 1330 dbSNP
rs1239143482 1332 dbSNP
rs552860361 1346 dbSNP
rs1030665570 1360 dbSNP
rs1000964374 1369 dbSNP
rs903757679 1371 dbSNP
rs528990330 1385 dbSNP
rs1166447104 1390 dbSNP
rs940272379 1396 dbSNP
rs1045359832 1398 dbSNP
rs1465009313 1400 dbSNP
rs947992541 1405 dbSNP
rs377538471 1412 dbSNP
rs1394023665 1437 dbSNP
rs1311745819 1438 dbSNP
rs1340032551 1444 dbSNP
rs1434142099 1445 dbSNP
rs1056233203 1446 dbSNP
rs1295201464 1447 dbSNP
rs1349250270 1448 dbSNP
rs1323924275 1453 dbSNP
rs938758237 1460 dbSNP
rs919372880 1461 dbSNP
rs1199025134 1476 dbSNP
rs1255922273 1478 dbSNP
rs1442636208 1480 dbSNP
rs1158048551 1489 dbSNP
rs972069555 1506 dbSNP
rs1472715623 1529 dbSNP
rs183732325 1533 dbSNP
rs1188971241 1543 dbSNP
rs1477964260 1553 dbSNP
rs1247840035 1563 dbSNP
rs1302029417 1568 dbSNP
rs1402732883 1583 dbSNP
rs1224205461 1588 dbSNP
rs568028029 1592 dbSNP
rs191297643 1595 dbSNP
rs570325595 1599 dbSNP
rs1218050507 1604 dbSNP
rs1278925210 1611 dbSNP
rs1331507482 1611 dbSNP
rs953611945 1615 dbSNP
rs144018425 1630 dbSNP
rs1366781085 1631 dbSNP
rs1346211087 1633 dbSNP
rs1213495979 1634 dbSNP
rs1030497884 1635 dbSNP
rs976287214 1635 dbSNP
rs956465740 1637 dbSNP
rs1362681939 1640 dbSNP
rs529778256 1644 dbSNP
rs1031197886 1660 dbSNP
rs1000635108 1663 dbSNP
rs1256012290 1678 dbSNP
rs1436306449 1679 dbSNP
rs1156647486 1700 dbSNP
rs1358786533 1710 dbSNP
rs1023262802 1716 dbSNP
rs1457397353 1718 dbSNP
rs1390419436 1721 dbSNP
rs114718904 1727 dbSNP
rs17847366 1731 dbSNP
rs746921899 1734 dbSNP
rs1236859708 1745 dbSNP
rs1413456132 1750 dbSNP
rs1284337539 1752 dbSNP
rs1352507948 1758 dbSNP
rs1216969569 1759 dbSNP
rs1261942619 1760 dbSNP
rs1487249223 1766 dbSNP
rs140314704 1769 dbSNP
rs1292215673 1770 dbSNP
rs1176485202 1782 dbSNP
rs146663203 1782 dbSNP
rs1379521460 1799 dbSNP
rs1193496353 1800 dbSNP
rs1160168221 1812 dbSNP
rs564845335 1814 dbSNP
rs530717097 1815 dbSNP
rs528293507 1829 dbSNP
rs1448213383 1840 dbSNP
rs1443825132 1859 dbSNP
rs1247735921 1862 dbSNP
rs1307524642 1863 dbSNP
rs1376685503 1866 dbSNP
rs1189640245 1867 dbSNP
rs1466392725 1869 dbSNP
rs1457068519 1870 dbSNP
rs80285632 1872 dbSNP
rs1308638590 1873 dbSNP
rs77138177 1873 dbSNP
rs199914027 1874 dbSNP
rs1220100958 1886 dbSNP
rs1237315351 1886 dbSNP
rs1319589391 1886 dbSNP
rs1440021820 1886 dbSNP
rs201814479 1886 dbSNP
rs398052579 1886 dbSNP
rs1209479950 1887 dbSNP
rs1312915749 1888 dbSNP
rs1410355208 1888 dbSNP
rs1280832379 1890 dbSNP
rs1395395216 1892 dbSNP
rs369460746 1896 dbSNP
rs897895173 1901 dbSNP
rs1443339291 1906 dbSNP
rs1281649103 1912 dbSNP
rs1036825049 1916 dbSNP
rs1227448509 1918 dbSNP
rs1296543564 1929 dbSNP
rs1293371852 1931 dbSNP
rs1435592020 1933 dbSNP
rs1336370712 1949 dbSNP
rs942144216 1960 dbSNP
rs909165870 1962 dbSNP
rs1458158783 1972 dbSNP
rs1206283753 1977 dbSNP
rs1235581163 1994 dbSNP
rs1482396085 2017 dbSNP
rs1446652289 2034 dbSNP
rs561117118 2039 dbSNP
rs1359173950 2043 dbSNP
rs1181538225 2053 dbSNP
rs777849361 2059 dbSNP
rs758462607 2075 dbSNP
rs1476200780 2078 dbSNP
rs1177624458 2086 dbSNP
rs541993690 2095 dbSNP
rs1423450679 2099 dbSNP
rs878971891 2100 dbSNP
rs1331279100 2104 dbSNP
rs1357859197 2109 dbSNP
rs1446796652 2117 dbSNP
rs1428332036 2124 dbSNP
rs932219745 2126 dbSNP
rs1390137446 2130 dbSNP
rs1277030013 2131 dbSNP
rs184740535 2139 dbSNP
rs1216325863 2140 dbSNP
rs1276203915 2149 dbSNP
rs1311437600 2182 dbSNP
rs1451774980 2186 dbSNP
rs1211362315 2200 dbSNP
rs1258442351 2203 dbSNP
rs1486779972 2215 dbSNP
rs1191525232 2220 dbSNP
rs1262646031 2230 dbSNP
rs976236382 2231 dbSNP
rs1181433148 2249 dbSNP
rs1423708543 2257 dbSNP
rs957064931 2257 dbSNP
rs1174657268 2259 dbSNP
rs1376830352 2265 dbSNP
rs1483708969 2286 dbSNP
rs1297036013 2287 dbSNP
rs9935 2292 dbSNP
rs73065894 2303 dbSNP
rs1272954055 2312 dbSNP
rs1366860858 2322 dbSNP
rs1234668703 2323 dbSNP
rs1203147984 2325 dbSNP
rs979555022 2329 dbSNP
rs967834363 2330 dbSNP
rs113280812 2338 dbSNP
rs747160959 2339 dbSNP
rs755277905 2342 dbSNP
rs754218382 2349 dbSNP
rs1454230421 2353 dbSNP
rs370818080 2361 dbSNP
rs1194638069 2363 dbSNP
rs960592569 2370 dbSNP
rs1344127513 2373 dbSNP
rs1310322466 2382 dbSNP
rs1227332447 2388 dbSNP
rs1385247494 2389 dbSNP
rs1034927799 2390 dbSNP
rs559312221 2399 dbSNP
rs994110673 2408 dbSNP
rs1304042153 2411 dbSNP
rs1441620657 2411 dbSNP
rs1407501581 2417 dbSNP
rs193260420 2419 dbSNP
rs1309230942 2424 dbSNP
rs1432171914 2438 dbSNP
rs761187523 2441 dbSNP
rs896956217 2442 dbSNP
rs1206910349 2444 dbSNP
rs1287881669 2448 dbSNP
rs1164544524 2451 dbSNP
rs188333567 2458 dbSNP
rs1424573815 2462 dbSNP
rs1416276549 2464 dbSNP
rs1214904876 2466 dbSNP
rs1255258585 2469 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions Jiyoye
Tools used in this research TargetScan
Original Description (Extracted from the article) ... HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO2. ...

- Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al., 2012, The EMBO journal.

Article - Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al.
- The EMBO journal, 2012
Epstein-Barr virus (EBV) controls gene expression to transform human B cells and maintain viral latency. High-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) identified mRNA targets of 44 EBV and 310 human microRNAs (miRNAs) in Jijoye (Latency III) EBV-transformed B cells. While 25% of total cellular miRNAs are viral, only three viral mRNAs, all latent transcripts, are targeted. Thus, miRNAs do not control the latent/lytic switch by targeting EBV lytic genes. Unexpectedly, 90% of the 1664 human 3'-untranslated regions targeted by the 12 most abundant EBV miRNAs are also targeted by human miRNAs via distinct binding sites. Half of these are targets of the oncogenic miR-17 approximately 92 miRNA cluster and associated families, including mRNAs that regulate transcription, apoptosis, Wnt signalling, and the cell cycle. Reporter assays confirmed the functionality of several EBV and miR-17 family miRNA-binding sites in EBV latent membrane protein 1 (LMP1), EBV BHRF1, and host CAPRIN2 mRNAs. Our extensive list of EBV and human miRNA targets implicates miRNAs in the control of EBV latency and illuminates viral miRNA function in general.
LinkOut: [PMID: 22473208]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
CESC 0.999 0.01 0.500 0.33 3 Click to see details
STAD -0.365 0.02 -0.426 0.01 32 Click to see details
COAD -0.71 0.02 -0.690 0.03 8 Click to see details
BLCA 0.467 0.03 0.472 0.02 18 Click to see details
PRAD -0.248 0.04 -0.205 0.08 50 Click to see details
CHOL 0.556 0.06 0.683 0.02 9 Click to see details
PAAD 0.833 0.08 0.800 0.1 4 Click to see details
HNSC -0.198 0.1 -0.138 0.19 42 Click to see details
THCA -0.164 0.11 -0.205 0.06 59 Click to see details
KIRP 0.214 0.12 0.219 0.11 32 Click to see details
ESCA -0.342 0.15 -0.255 0.22 11 Click to see details
LUAD 0.324 0.15 0.378 0.11 12 Click to see details
LIHC -0.142 0.17 -0.207 0.08 49 Click to see details
BRCA -0.099 0.19 -0.192 0.04 84 Click to see details
PCPG -0.764 0.22 -0.500 0.33 3 Click to see details
LUSC 0.121 0.23 0.181 0.14 38 Click to see details
UCEC -0.154 0.26 -0.109 0.33 19 Click to see details
KIRC 0.067 0.29 0.180 0.07 68 Click to see details
KICH 0.039 0.43 0.068 0.37 25 Click to see details
KICH 0.039 0.43 0.068 0.37 25 Click to see details
KICH 0.039 0.43 0.068 0.37 25 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission